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Background: Recent evidence indicates that histamine, acting on histamine 1 receptor (H1R), resets the circadian
clock in the mouse suprachiasmatic nucleus (SCN) by increasing intracellular Ca2+ concentration ([Ca2+]i) through
the activation of CaV1.3 L-type Ca
2+ channels and Ca2+-induced Ca2+ release from ryanodine receptor-mediated
internal stores.
Results: In the current study, we explored the underlying mechanisms with various techniques including Ca2+- and
Cl−-imaging and extracellular single-unit recording. Our hypothesis was that histamine causes Cl− efflux through
cystic fibrosis transmembrane conductance regulator (CFTR) to elicit membrane depolarization needed for the
activation of CaV1.3 Ca
2+ channels in SCN neurons. We found that histamine elicited Cl− efflux and increased [Ca2+]i
in dissociated mouse SCN cells. Both of these events were suppressed by bumetanide [Na+-K+-2Cl− cotransporter
isotype 1 (NKCC1) blocker], CFTRinh-172 (CFTR inhibitor), gallein (Gβγ protein inhibitor) and H89 [protein kinase A (PKA)
inhibitor]. By itself, H1R activation with 2-pyridylethylamine increased the level of cAMP in the SCN and this regulation
was prevented by gallein. Finally, histamine-evoked phase shifts of the circadian neural activity rhythm in the mouse
SCN slice were blocked by bumetanide, CFTRinh-172, gallein or H89 and were not observed in NKCC1 or CFTR KO mice.
Conclusions: Taken together, these results indicate that histamine recruits the H1R-Gβγ-cAMP/PKA pathway in the SCN
neurons to activate CaV1.3 channels through CFTR-mediated Cl
− efflux and ultimately to phase-shift the
circadian clock. This pathway and NKCC1 may well be potential targets for agents designed to treat problems
resulting from the disturbance of the circadian system.
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Histamine, a neurotransmitter/neuromodulator produced
by tuberomammillary nucleus (TMN) neurons in the
hypothalamus [1], has a crucial role in regulating brain
arousal [2]. A large body of evidence indicates that his-
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from the TMN densely innervate the master circadian
clock suprachiasmatic nucleus (SCN) in the rat [3–5]
and exogenously applied histamine exerts a phase-
shifting effect on the circadian neural activity rhythms
recorded in the hamster and mouse SCN slices main-
tained in vitro [6, 7] and on the circadian behavior
rhythms manifested in rats [8]. Moreover, histamine
synthesis inhibition disrupts circadian activity rhythms
in the rat [8] and reduces the phase shifts of circadian
activity rhythms induced by light in the hamster [9].distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Kim et al. Molecular Brain  (2016) 9:49 Page 2 of 11It is well established that 4 different types of histamine
receptors (i.e., H1R ~H4R) mediate histaminergic actions
and that the H1R, which is linked to the Gq/11-phosphola-
pase C (PLC) pathway, mediates a majority of excitatory
actions of histamine in the central nervous system [2, 10].
The Gq/11-PLC pathway leads to diacyl-glycerol (DAG) and
inositol 1,4,5-trisphosphate (IP3) production [2, 10]. While
DAG can cause Ca2+ influx through the transient receptor
potential cation channel (TRPC), IP3 induces Ca
2+ release
from the internal stores via IP3 receptor [10, 11].
Recently, we demonstrated that histamine, acting on
H1R, increases intracellular Ca2+ concentration ([Ca2+]i)
in mouse SCN neurons by a novel mechanism driven by
CaV1.3 L-type Ca
2+ channels as well as Ca2+-induced
Ca2+ release from ryanodine receptor (RyR)-mediated in-
ternal stores and this is the molecular mechanism
underlying the histamine-induced phase delay of circa-
dian neural activity rhythm in the SCN [12]. In the
present study, we sought to delineate the novel signaling
mechanisms leading to L-type Ca2+ channel opening after
H1R activation. Prior works have shown that histamine
regulate Cl− conductances in neurons [13, 14] and that, in
some SCN neurons, the electrochemical gradient for Cl− is
set toward the extracellular side due to the Cl−-importing
activity of Na+-K+-2Cl− cotransporter isotype 1 (NKCC1)
[15, 16]. Therefore, we hypothesized that histamine
causes Cl− efflux to elicit membrane depolarization
needed for L-type Ca2+ channel activation. We consid-
ered the possibility that the cystic fibrosis transmem-
brane conductance regulator (CFTR) may mediate the
histamine-induced Cl− efflux because Allen Brain Atlas
([17], http://www.brain-map.org) indicates the presence
of CFTR mRNA in the mouse SCN. Prior works also
indicate that H1R is positively coupled through the Gβγ
protein to the cAMP signaling pathway [18, 19], which
can lead to CFTR activation by stimulating protein kin-
ase A (PKA) [20–24]. Here we present results indicat-
ing that the Gβγ-cAMP/PKA-CFTR pathway links H1R
to L-type Ca2+ channels and this pathway is essential




The procedures of experiments employed in the current
study were approved by the Animal Research Policies
Committees of Korea University College of Medicine
and Korea Institute of Science and Technology. Also,
they conformed to the guidelines of National Institutes
of Health of the United States of America.
Animals and housing
Male C57BL/6 mice (B6 mice, 3–6 week-old) bred in
Korea Institute of Science and Technology were used forCa2+ imaging, Cl− imaging, enzyme immunoassays (EIA)
and extracellular single-unit recording experiments. In
addition, male knock-out (KO) mice (3–6 week-old) for
NKCC1 (Slc12a2−/−) or CFTR (B6.129P2-Cftrtm1Unc/J),
obtained from Professor Min Goo Lee at Yonsei University
(Seoul, Korea), were used in some of these experiments.
Before being used, the mice were housed in group cages
(4–6/cage) in a vivarium (22–24 °C) with a 12 h/12 h
light/dark cycle for ≥ 1 week. The times of lights-on
and -off in the vivarium were designated as zeitgeber
time (ZT) 0:00 h and ZT 12:00 h, respectively.
Preparation of brain slices
Brain slices were prepared between ZT 10:00 h and
ZT12:00 h. Under urethane anesthesia (1.25 g/kg, i.p.),
the brain was quickly resected and put in aerated (95 %
O2/5 % CO2) ice-cold artificial cerebrospinal fluid
(ACSF), which was composed of (in mM) 124 NaCl, 1.3
MgSO4, 3 KCl, 1.25 NaH2PO4, 26 NaHCO3, 2.4 CaCl2
and 10 glucose. After being chilled in the ACSF for 1–
2 min, the brain was cut into slices (300–400 μm thick-
ness) in ice-cold ACSF using a vibroslicer (World Precision
Instruments or Leica VT100S). The slices containing the
SCN were selected and kept in aerated (95 % O2/5 % CO2)
ACSF at room temperature (R/T, 30–60 min) before being
used for SCN cell dissociation or being transferred to an
electrophysiological recording chamber, which was con-
tinuously perfused with aerated (95 % O2/5 % CO2) ACSF
(35 °C).
SCN cell dissociation
The hypothalamic slices incubated in aerated ACSF as
above were used for SCN cell dissociation. The proce-
dures for the cell dissociation were identical to those de-
scribed previously [12].
Ca2+ imaging
The Ca2+ imaging methods employed in this study were
identical to those described previously [12]. [Ca2+]i was
expressed as the ratio of intensities of the fura-2 emis-
sion fluorescence of 510 nm, excited at 340 and 380 nm.
All the Ca2+-imaging experiments (as well as Cl−-im-
aging study, below) were carried out between ZT
13:00 h and ZT 18:00 h.
Cl− imaging
To measure changes of intracellular Cl− concentrations
([Cl−]i), the Cl
− sensor N-(ethoxy carbonyl methyl)-6-
methoxyquinolinium bromide (MQAE, Invitrogen, CA)
was used. This sensor shows the highest fluorescence in
the absence of Cl−, and therefore, a decrease of the mon-
itored fluorescence represents an increase in [Cl−]i, and
vice versa. Dissociated SCN cells plated on poly-D-
lysine-coated glass coverslips were incubated for 2 h in
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and then rinsed with HEPES-buffered saline before be-
ing moved to an imaging chamber mounted on an
inverted microscope (IX70, Olympus). MQAE was ex-
cited at 350 nm and emitted at 460 nm. Imaging data
were acquired with the use of an intensified CCD cam-
era (CasCade, Roper Scientific) and Metafluor software
(Molecular Device). Changes in [Cl−]i were calculated
as ΔF with
ΔF ¼ F‐F0ð Þ
F0
where F is the fluorescence at each time point and F0 is
the average of the fluorescence measured at the first ten
time points.
Microdissection of the SCN and cAMP measurement
Brain slices (350-μm thickness) were prepared from B6
mice (4 ~ 5 week-old) as described above. After being
treated with drugs (see Results) for 30 min starting at
ZT 14:00 h, the slices were mounted on a silicon rubber
stage chilled with dry-ice powder. The SCN on both the
left and right sides were punched out from the frozen
section with the use of a blunt needle (21 G) under a
dissecting microscope. The SCN punches from each
hypothalamic slice were pooled in 0.1-N HCl solution
(300 μl) and then sonicated with Bioruptor (COSMO
BIO, Japan) at 4 °C. The concentration of cAMP was de-
termined with the use of Cyclic AMP EIA kit (Cayman
Chemical, MI) according to the manufacturer’s protocol.
The protein content was determined with Pierce™ BCA
Protein Assay Kit (Thermo scientific, MA). Following
centrifugation at 1,000 g for 10 min, the supernatant was
diluted 1:2 with EIA buffer (Cayman Chemical). All SCN
samples were acetylated prior to the determination of
cAMP level by EIA. The assays were performed in dupli-
cate, with measurement at λ = 405 nm on a micro plate
reader (SPECTRA max plus 384, Molecular Devices, CA).
Experimental treatment and single-unit recording
On the first day, the slice was treated with histamine for
30 min from ZT 14:00 h. In certain experiments, hista-
mine was applied to the slice along with bumetanide
(NKCC blocker), gallein (Gβγ blocker), CFTRinh-172
(CFTR blocker), H89 (PKA blocker) or KT5720 (PKA
blocker). The application of these drugs commenced at
ZT 13:50 h and lasted for 50 min. Control slices were
challenged neither with histamine nor with any of the
blockers above.
On the second day, single-unit recordings were ob-
tained extracellularly from the SCN at ZT 1:00–15:00 h.
To detect the time at which the peak of circadian firing
activity rhythm of SCN neurons occurs (i.e., a reliablemarker of the phase of circadian clock [25]), we plotted
against ZT the average firing rates of randomly sampled
single units for sequential 2-h periods with 1-h lags [25].
To quantify the phase shift resulting from a drug treat-
ment, we measured the difference of the time-of-peak
found in the experimental slice from the average time-
of-peak of control slices [12, 25].
Drugs
Drugs and chemicals utilized in the present study were
from Sigma-Aldrich (St. Louis, MO) or Tocris Bio-
science (Bristol, UK). The solutions of histamine
(100 μM; [26–28]), 2-pyridylethylamine (100 μM; [29–33])
and amthamine (20 μM; [34–36]) were prepared in ACSF
or HEPES-buffered saline. The solutions of bumetanide
(10 μM; [16, 37, 38]), CFTRinh-172 (50 μM; [39–41]), gal-
lein (100 μM; [42–44]), H89 (10 μM; [45–47]), KT5720
(1 μM; [48–50]), bicuculline (30 μM; [51–53]) and strych-
nine (1 μM; [54–56]) were prepared by diluting the stock
solutions with ACSF or HEPES-buffered saline; the solvent
of stock solutions was dimethyl sulphoxide and its final
concentration was 0.01–0.003 %. The drug solutions were
applied to SCN slices or dissociated SCN cells by peristal-
tic pump or gravity-fed bath-perfusion system [15].
Statistics
Numerical data are expressed as the mean ± SEM. Stu-
dent t-test and Mann–Whitney Rank Sum test were
employed to compare two independent data sets with
and without normal distribution, respectively. Paired
samples having normal distribution were compared with
paired t-test while paired samples without normal distri-
bution with Wilcoxon Signed Rank test. One-way ana-
lysis of variance (ANOVA) and pairwise comparison
with Student-Newman Keuls tests were performed to
compare ≥3 independent data sets having normal distri-
butions, while Kruskal-Wallis one-way ANOVA on
ranks and pairwise comparison with Student-Newman
Keuls tests were performed to compare ≥ 3 data sets
lacking normal distributions. Chi-square test was used
to determine whether there is a significant difference be-
tween the expected frequencies and the observed fre-
quencies in one or more categories. P < 0.05 (two-sided)
was considered significant.
Results
Histamine induces the efflux of NKCC1-accumulated Cl−
and, through this mechanism, activates L-type Ca2+
channels in SCN neurons
To test our hypothesis, we first examined how the NKCC
inhibitor bumetanide affects the histamine (100 μM, 30 s)-
elicited rise in [Ca2+] in dissociated SCN neurons and
whether NKCC1 KO mouse neurons would show an al-
tered histamine response. Bumetanide (10 μM) attenuated
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0.06 to 0.20 ± 0.05) or converted the rise into fall in 40 of
105 cells (0.47 ± 0.04 to −0.31 ± 0.12) (Fig. 1a). In the
remaining cells, it did not affect (7 of 105 cells; 0.77 ±
0.09 vs. 0.78 ± 0.09) or enhanced the histamine-elicited
Ca2+ increase (17 of 105 cells; 0.32 ± 0.06 to 0.61 ± 0.08)
(Fig. 1a). These effects of bumetanide were statistically
significant [t(104) = 8.302, p < 0.001, paired t-test]. Like-
wise, histamine-evoked Ca2+ response was reduced in
SCN neurons prepared from NKCC1 KO mice. In the
KO mice, histamine application caused Ca2+ rise in
31 % of the neurons (28 of 90 cells from 2 mice) with
an average increase of 0.30 ± 0.04 (Δ ratio 340/380). In
wild-type mice, histamine application resulted in an
increase in Ca2+ level in 60 % of the neurons (116 of 192
cells from 3 mice) with an average increase of 0.50 ± 0.03
(Δ ratio 340/380). Thus, in NKCC1 KO mice, the propor-
tion of cells showing histamine-induced Ca2+ response wasa
b
c
Fig. 1 Histamine induces the efflux of NKCC1-accumulated Cl−, leading to
Ca2+-imaging experiment which show the effect of bumetanide on histam
summarizing the effects of bumetanide on the histamine-elicited Ca2+ resp
mean (± SEM) peak Ca2+ responses. b Traces from Cl−-imaging experiments s
deflections of the trace denote decrease and increase in [Cl−]i, respectively. c
agonist-induced decrease (n = 81) and increase (n = 80) in [Cl−]i in SCN ce
symbols connected by lines in (a) and (c) denote data from the same celsignificantly reduced [Chi-square(2) = 44.282, p < 0.001,
Chi-square test] as well as the average magnitude of the
response [U = 2120, p < 0.001, Mann–Whitney Rank Sum
test]. Taken together, these results support the hypothesis
that histamine induces the efflux of NKCC1-accumulated
Cl− in at least a subset of SCN neurons and through that
mechanism increases [Ca2+]i.
In order to obtain more direct evidence that hista-
mine causes Cl− efflux in SCN neurons, we next per-
formed Cl−-imaging experiments using the fluorescent
Cl− sensor MQAE. Bath application of the H1R agonist
2-pyridylethylamine (100 μM, 30 s) but not the H2R
agonist amthamine (20 μM, 30 s), resulted in a reliable
decrease in [Cl−]i in a subset of dissociated SCN cells
(450 of 1121 cells from 26 mice) (Fig. 1b, left trace); the
average peak amplitude of the H1R agonist-induced Cl−
response (ΔF) was 0.054 ± 0.003 (n = 450). In the
remaining cells, H1R agonist produced either an increaseintracellular Ca2+ rise in SCN neurons. (a, left panel) Traces from a
ine-elicited increase in [Ca2+]i in an SCN neuron. (a, right panel) Graphs
onses in 105 SCN neurons from 3 mice. The bar charts indicate the
how the effects of H1R agonist on [Cl−]i in SCN cells. Up- and downward
Traces and summary graphs showing the effects of bumetanide on H1R
lls. The bar charts indicate the mean (± SEM) peak Cl− responses. The
ls. **: p < 0.001, paired t-test
Fig. 2 H1R activation increases the cAMP level in the SCN through
the Gβγ protein. Graph showing the effects on the content of cAMP
in the mouse SCN tissue, of H1R (2-pyridylethylamine, 100 μM, n = 5
mice) and H2R (amthamine, 20 μM, n = 5 mice) agonists alone or in
combination with the Gβγ inhibitor gallein (100 μM, n = 6 mice).
Control: n = 5 mice. One-way ANOVA followed by Student-Newman-
Keuls pairwise comparison test (*: p < 0.05)
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change in [Cl−]i (n = 296). After bumetanide (10 μM)
treatment, the H1R agonist-induced decrease in [Cl−]i was
converted into an increase [n = 81 cells from 4 mice,
ΔF = 0.053 ± 0.003 to −0.094 ± 0.003; t(80) = 35.258,
p < 0.001, paired t-test)] while the H1R agonist-induced
increase in [Cl−]i was enhanced [n = 80 cells from 4 mice,
ΔF = -0.038 ± 0.002 to −0.094 ± 0.004; t(79) = 15.929,
p < 0.001, paired t-test) (Fig. 1c). Collectively, these re-
sults indicate that histamine causes efflux of NKCC1-
accumulated Cl− in a subset of SCN neurons.
H1R-Gβγ-cAMP/PKA pathway mediates histamine
response
Previous work suggests that H1R is positively linked
to cAMP signaling pathway through the Gβγ protein
[18, 19], and it is well known that cAMP is a strong
PKA activator [57, 58]. Thus, we next explored the possi-
bility that the Gβγ protein arising from the activation of
H1R promotes the cAMP production to activate PKA and
ultimately to bring about histamine-induced responses in
SCN neurons. To this end, we examined whether H1R ac-
tivation leads to the increase in cAMP level in the SCN
and, if so, the treatment of gallein (Gβγ protein inhibitor)
blocks this increase, and whether gallein and the PKA
blocker H89 suppress the H1R agonist-elicited Ca2+
and Cl− responses in dissociated SCN cells. We found
that application of the H1R agonist 2-pyridylethylamine
(100 μM, for 30 min starting at ZT 14:00 h), but not
the H2R agonist amthamine (20 μM, for 30 min starting
at ZT 14:00 h), resulted in a significant increase in cAMP
content in the SCN and this effect was precluded by co-
applied gallein (100 μM) [one-way ANOVA: F(3,17) =
3.828, p = 0.029, Student-Newman-Keuls pairwise com-
parison tests: Control vs. H1R agonist: p = 0.037, Con-
trol vs. H2R agonist: p = 0.170; Control vs. H1R agonist
+ gallein: p = 0.635; H1R agonist vs. H2R agonist: p =
0.289; H1R agonist vs. H1R agonist + gallein: p = 0.043;
H2R agonist vs. H1R agonist + gallein: p = 0.153] (Fig. 2).
Moreover, we discovered that both gallein (100 μM)
and H89 (10 μM) generally suppressed the H1R agonist
(100 μM, 30 s)-elicited Ca2+ and Cl− responses (Fig. 3).
Thus, taken together, these results suggested that the
H1R-Gβγ-cAMP/PKA pathway mediates histamine-elicited
responses in SCN neurons.
CFTR mediates histamine-induced Cl− efflux
In order to better understand the histaminergic regula-
tion of Cl− in SCN neurons, we then explored the pos-
sible role of CFTR, the PKA-activated Cl− channel.
Specifically, we examined the effects of the CFTR inhibi-
tor CFTRinh-172 on histamine (or H1R agonist)-induced
responses in SCN cells. We found that the application of
CFTRinh-172 (50 μM) blocked both Cl
− efflux [ΔF:0.111 ± 0.035 to 0.003 ± 0.003, n = 41 cells from 4 mice;
W= -861, p < 0.001, Wilcoxon Signed Rank test; Fig. 4a
and b, left panel] and influx [ΔF: −0.108 ± 0.011 to 0.002 ±
0.002, n = 38 cells from 4 mice; W= 741, p < 0.001,
Wilcoxon Signed Rank test; Fig. 4b, right panel] induced by
2-pyridylethylamine (H1R agonist; 100 μM, 30 s) in SCN
cells. Furthermore, we discovered that CFTRinh-172 attenu-
ated significantly the histamine (100 μM, 30 s)-elicited Ca2+
rise in SCN neurons [0.53 ± 0.05 to 0.15 ± 0.03, n = 31 cells
from 3 mice; t(30) = 6.849, p < 0.001, paired t-test] (Fig. 4c).
Collectively, these results indicated that CFTR mediates
histamine-induced Cl− fluxes in SCN neurons.
Histamine resets the circadian clock through the
Gβγ-cAMP/PKA-CFTR pathway
Our previous work has indicated that, in order to reset
the circadian clock, histamine raises [Ca2+]i in SCN neu-
rons by activating the CaV1.3 L-type Ca
2+ channels
through H1R, and secondarily by causing Ca2+-induced
Ca2+ release from RyR-mediated internal stores [12].
a b
c d
Fig. 3 Gβγ-cAMP/PKA signaling pathway plays a crucial role in H1R agonist-elicited Ca
2+ rise and Cl− fluxes. a Summary graphs showing the
effects of the Gβγ blocker gallein on H1R agonist-elicited increase in [Ca
2+]i. The bar charts indicate the mean (± SEM) peak Ca
2+ responses. **: p< 0.001
[n= 47 neurons from 3 mice, t(46) = 10.409, paired t-test]. b Summary graphs showing the effects of gallein on H1R agonist-induced Cl− efflux [left panel,
n= 21 cells from 4 mice, t(20) = 6.783, p< 0.001, paired t-test] and influx [right panel, n= 50 cells from 4 mice, t(49) = −14.644, p< 0.001, paired t-test]. The
bar charts indicate the mean (± SEM) peak Cl− responses. **: p < 0.001. c Summary graphs showing the effects of the PKA inhibitor H89 on
H1R agonist-elicited increase in [Ca2+]i. The bar charts indicate the mean (± SEM) peak Ca
2+ responses. **: p < 0.001 [n = 90 neurons from 3
mice, t(89) = 7.272, paired t-test]. d Summary graphs showing the effects of H89 on H1R agonist-induced Cl− efflux [left panel, n = 277 cells
from 8 mice, t(276) = 19.895, paired t-test] and influx [right panel, n = 90 cells from 8 mice, t(89) = −11.458, paired t-test]. The bar charts indicate
the mean (± SEM) peak Cl− responses. **: p < 0.001. The symbols connected by lines in (a-d) denote data from the same cells
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Gβγ-cAMP/PKA-CFTR pathway is responsible for link-
ing H1R to L-type Ca2+ channel. To further test this
hypothesis, we investigated how the pharmacological
blockade or genetic removal of Gβγ, PKA, CFTR or
NKCC1 altered the histamine-elicited phase delay of
circadian neural activity rhythm in the mouse SCN
slice. In the control slices, the peak of the circadian
neural activity rhythm occurred at ZT 6.00 ± 0.33 h (n = 6;
Fig. 5a and k). In the histamine (100 μM)-treated slices,
the peak was phase-delayed about 6 h to ZT 11.67 ±
0.21 h (n = 6; Fig. 5b and k) by the next cycle [6, 12]. This
histamine effect on the circadian phase was almost com-
pletely blocked by the co-applied inhibitors of Gβγ (gallein,
100 μM), PKA (H89, 10 μM; KT5720, 1 μM), CFTR
(CFTRinh-172, 50 μM) and NKCC (bumetanide, 10 μM)
(Fig. 5c-f and k), but not by the GABAA receptor antag-
onist bicuculline (30 μM) or the glycine receptor antag-
onist strychnine (1 μM) (Fig. 5g, h and k). In addition,
the histamine-elicited phase delays were absent in KOmice lacking CFTR and NKCC1 (Fig. 5i-k). In control
experiments, we found that application of the blockers
alone or the genetic loss of CFTR and NKCC1 did not
alter the phase of the circadian rhythm. The time of
peak electrical activity of SCN neurons recorded in the
slices treated with either gallein [ZT 6.5 ± 0.3 h, n = 4;
p = 0.242, t(8) = −1.265, t-test], H89 [ZT 5.8 ± 0.3 h, n =
4; p = 0.610, U = 14.5, Mann–Whitney Rank Sum Test],
CFTRinh-172 [ZT 5.5 ± 0.3 h, n = 4; p = 0.242, t(8) =
1.265, t-test] or bumetanide alone [ZT 6.5 ± 0.3 h, n = 4;
p = 0.242, t(8) = −1.265, t-test] was not significantly dif-
ferent from that of neurons recorded in drug-untreated,
control slices (ZT 6.00 ± 0.33 h, n = 6). Likewise, the
time of peak electrical activity of SCN neurons re-
corded in the slices from CFTR KO [ZT 6.3 ± 0.5 h, n =
4; p > 0.999, U = 12, Mann–Whitney Rank Sum test] or
NKCC1 KO mice [ZT 6.0 ± 0.4 h, n = 4; p > 0.999, U =
12, Mann–Whitney Rank Sum Test] was not signifi-
cantly different from that of neurons recorded in the
slices from wild-type animals (ZT 6.00 ± 0.33 h, n = 6).
ab c
Fig. 4 The CFTR inhibitor CFTRinh-172 suppresses histamine-elicited Cl
− efflux and Ca2+ rise in SCN cells. a Traces from Cl−-imaging experiments
that show the inhibitory effects of CFTRinh-172 on 2-pyridylethylamine (H1R agonist)-induced Cl
− efflux in an SCN cell. b Summary graph showing
the effect of CFTRinh-172 on H1R agonist-induced Cl
− efflux (n = 41 cells from 4 mice; left panel) and influx (n = 38 cells from 4 mice; right panel)
in SCN cells. c Summary graph showing the effect of CFTRinh-172 on histamine-elicited increase in [Ca
2+]i in SCN neurons (n = 31 neurons from 3
mice). The bar charts in (b) and (c), respectively, indicate the mean (± SEM) Cl− and Ca2+ responses elicited by H1R agonist or histamine in the
absence or presence of CFTRinh-172. The symbols connected by lines in (b) and (c) denote data from the same cells. **: p < 0.001
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assay further supported our hypothesis that the Gβγ-
cAMP/PKA-CFTR pathway links H1R to CaV1.3 L-type
Ca2+ channels in SCN neurons, leading to the resetting
of the circadian clock (Fig. 6).
Discussion
In a recent communication [12] we reported that, in
order to reset the circadian clock in the mouse SCN,
histamine increases [Ca2+]i in SCN neurons by activating
the CaV1.3 L-type Ca
2+ channels through H1R, and sec-
ondarily by causing Ca2+-induced Ca2+ release from
RyR-mediated internal stores. Moreover, we provided
evidence that IP3 and DAG, the downstream of PLC, are
not involved in the H1R-mediated rise in [Ca2+]i. In the
current study, we explored the signaling mechanism that
links the H1R to the CaV1.3 channels and obtained the
results indicating that, in a subset of SCN neurons
loaded with Cl− by NKCC1, histamine causes Cl− efflux
through H1R to produce membrane depolarization
needed for the activation of CaV1.3 channels. CFTR is
well known as anion channel whose malfunction leads
to dysregulation of epithelial fluid transport in the lung,
pancreas and other organs, resulting in cystic fibrosis
[22, 24, 59]. In this study, we present evidence that
CFTR mediates the histamine-elicited Cl− efflux in SCN
cells while the Gβγ-cAMP/PKA pathway downstream of
H1R activates the CFTR. Studies have provided evidence
that histamine-activated Cl− channels are expressed inmammalian brain [13, 14] and that CFTR mRNA exists
in the mouse SCN ([17], http://www.brain-map.org).
Also, it has been reported that H1R is positively coupled
through the Gβγ protein to the cAMP signaling pathway
[18, 19], which can activate CFTR by up-regulating PKA
[20–24]. Nevertheless, the H1R-mediated signaling path-
way that involves CFTR has never been reported. To the
best of our knowledge, the current study is the first to
provide the evidence for the existence of such a signaling
pathway. Also, this study is the first to present evidence
indicating that CFTR has a functional role in the circa-
dian time-keeping system.
In the current study we noticed that, even after the
blockade of CFTR, a significant proportion of SCN neu-
rons still responded to histamine with an increase in
[Ca2+]i although the magnitudes of the responses were
significantly smaller. This finding suggests that mecha-
nism(s) other than the membrane depolarization arising
from CFTR-mediated Cl− efflux also contributes to the
L-type Ca2+ channel activation by histamine. The pos-
sible mechanisms include the direct activation of the
Ca2+ channel by PKA [60–63] and the blockade of leak
K+ channels through the H1R-coupled Gq/11 protein [2],
which can produce the membrane depolarization needed
for the activation of the Ca2+ channels. Whether these
mechanisms operate in SCN neurons for the histaminer-
gic activation of L-type Ca2+ channels and, if so, whether
they work along with the “CFTR” mechanism in the








Fig. 5 Effect of blockade/KO of Gβγ, PKA, CFTR or NKCC1 on
histamine-induced resetting of circadian clock. a-j Plots against
ZT of the firing rate of SCN neurons recorded in different experimental
conditions. Each plot shows the representative result of 6 repeated
experiments. The projected light and dark phases of the animal
room are indicated with open and filled horizontal bars, respectively.
The dashed vertical line in each plot indicates the average time of peak
neural activity for control slices. The filled square denotes the
time of slice preparation, while the arrow indicates the time of drug
application. k Graph summarizing the effects of various experimental
treatments on the time of peak of circadian firing activity rhythm.
Student-Newman-Keuls comparison tests were performed after
Kruskal-Wallis one-way ANOVA on Ranks (p < 0.001). The results of
pair-wise comparisons of the value of each experimental group
with those of control and histamine groups are denoted with as-
terisk and spade, respectively. *, ♠: p < 0.05
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is crucial for the histamine-elicited increase in [Ca2+]i in
SCN neurons and the subsequent resetting of the
circadian clock in the SCN. By importing Cl−, NKCC1
provides the driving force for the histamine-elicited
Cl− efflux through CFTR which produces membranedepolarization needed for the activation of L-type Ca2+
channels. Our data do not suggest that histamine effects
depend on GABAergic and/or glycinergic transmission,
the polarity and strength of the postsynaptic responses of
which can be regulated by NKCC1. This view is consistent
with the finding that histamine caused [Ca2+]i to rise in
dissociated SCN neurons which were no longer under
synaptic control. Moreover, it is consistent with the obser-
vation that both bicuculline and strychnine had no signifi-
cant effects on the histamine-elicited phase delay of the
circadian neural activity rhythm in the SCN slice.
The present study demonstrates that, in certain SCN
cells (~33 % cells examined), H1R activation led to Cl−
influx, instead of efflux. This is presumably because of
that, in these cells, the NKCC1 activity was low or absent
such that the electrochemical gradient for Cl− was set
toward the intracellular side. At present, we do not know
the functional significance of the histamine-induced
Cl− influx. However, it is unlikely that this Cl− flux pro-
moted histamine to phase-delay the circadian pacemaker
in the SCN, since the blockade of NKCC1 by bumetanide,
which converted the H1R agonist-induced Cl− efflux into
influx in some cells and enhanced the H1R agonist-
induced Cl− influx in other cells, resulted in a complete
blockade of the histamine-elicited phase shift.
Significance
A variety of evidence indicates that histamine is a potent
regulator of the phase of the circadian system. Prior
work has shown that histamine application onto SCN
neurons in the rat and hamster hypothalamic slices in-
creases or decreases the electrical activities of these cells
[64–66] while bath-applied histamine phase-shifts the
circadian neural activity rhythms recorded in hamster
and mouse SCN slices [6, 7, 27]. The inhibition of hista-
mine synthesis by α-fluoromethylhistidine decreases the
phase shifts of circadian activity rhythms induced by
light in the hamster [9]. Injection of histamine into the
cerebral ventricle in the rat leads to the phase shifts of
circadian activity rhythms [8] and decreases the time
needed to entrain activity rhythms to an abruptly ad-
vanced light–dark cycle [67]. In our own work, we dem-
onstrated that histamine acts on H1R to alter the phase
of the circadian clock in the mouse SCN and this effect
depends on the increase of [Ca2+]i which results from
the activation of CaV1.3 L-type Ca
2+ channels and Ca2
+-induced Ca2+ release from RyR-mediated internal
stores [12]. In the present study, we further explored the
signal transduction mechanisms and present evidence
that the Gβγ-cAMP/PKA-CFTR pathway is intercalated
between H1R and the L-type Ca2+ channels. These re-
sults clearly delineate a novel signaling mechanism that
underlies the histamine-induced resetting of the circa-
dian clock.
Fig. 6 Proposed signaling pathway for histamine-induced resetting of the circadian pacemaker in the SCN. ① A subset of SCN neurons are
loaded with Cl− by the action of the Cl− importer NKCC1. ② H1R stimulation by histamine at early night results in the production of activated
Gβγ protein in these cells. ③ The activated Gβγ protein stimulates adenylate cyclase (AC) to produce cAMP from ATP. ④ PKA activated by cAMP
opens the Cl− channel CFTR. ⑤ The efflux of Cl− through CFTR down the electrochemical gradient results in membrane depolarization. ⑥ In
response to this membrane depolarization, the CaV1.3 L-type voltage-gated Ca
2+ channel (VGCC) is activated. ⑦ The resulting Ca2+ influx
through CaV1.3 VGCC induces Ca
2+ release from the endoplasmic reticulum (ER) through RyR. ⑧ The consequent increase in [Ca2+]i leads to
phase delay of the circadian clock
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about the role of histamine in the generation of circadian
rhythms in vivo and the functional significance of the
phase control remains unclear. Among the complications
is evidence for species-specific differences as Scott et al.
[66] showed that the hamster SCN is almost devoid of
histaminergic fibers and that histamine has only a weak
phase-shifting effect on the free-running locomotor ac-
tivity rhythm. In addition, the inhibition of histamine
synthesis by α-fluoromethylhistidine or the KO of histi-
dine decarboxylase gene disrupted the circadian activity
rhythm in the rat [8] and lowered the levels of wheel-
running and spontaneous locomotor activities in mice
in both light–dark and dark-dark conditions [68]. These
findings raise the possibility that histamine may be in-
volved in the generation of the rhythms as well as phase
control. The receptor mediating these effects is less
clear. Studies on H1R KO mice found disrupted diurnal
feeding rhythm [69] but essentially normal locomotor
activity rhythms [70]. In contrast, the H3R KO mice ex-
hibited a greatly reduced locomotor activity rhythm but
normal rhythms in clock gene expression [70]. Unfortu-
nately, the studies with the KO mice did not examine
whether these genetic manipulations altered the photic
regulation of the circadian cycle. Taken together, these
data indicate that histamine is a potent regulator of thecircadian time-keeping system in some mammals and
suggest that the H1R signaling is important for phase
control while the H3R signaling may be more import-
ant for regulation of the amplitude of circadian rhythms
in activity.
Conclusions
In summary, we present experimental results indicating
that, in order to activate Ca 1.3 L-type Ca channels in
SCN neurons and ultimately to phasedelay the circadian
clock in the SCN, histamine recruits the H1R-G -cAMP/
PKACFTR pathway in the SCN neurons loaded with Cl
by NKCC1. This pathway and NKCC1 may well be po-
tential targets for drugs designed to treat clinical prob-
lems resulting from the disturbance of the circadian
system.
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